Biotechnology company Cardio3 BioSciences SA, leader in the development of regenerative, protective and reconstructive medicine for treating cardiac diseases, was elected the most innovative business in Wallonia for the year 2013 at the Trends-Tendances Tour 2013 award ceremony for Wallonia on Wednesday 20th November 2013.
With the collaboration of the Walloon Foreign Trade and Investment Agency (AWEX) and Business & Society, the Trends Tendances Business Tour honoured three businesses active in sustainable management, export and innovation.
Cardio3 BioSciences's most advanced treatment is C-Cure®. It's an innovative approach to the use of cells for treating heart failure. More precisely, it consists in removing cells from the patient's bone marrow and reprogramming them so that they become cardiac precursor cells thanks to a revolutionary, patented procedure owned by the business. Furthermore, this research published in international reviews has also achieved prestigious prizes in the United States.
Doctor Christian Homsy, CEO of Cardio3 BioSciences, comments: "We are happy and very honoured to win the Trends-Tendances Business Tour prize from among the most innovative companies in Wallonia. For a number of years, we've been working on developing another medical approach. Alongside others working in regenerative medicine, together we're inventing a new industry, a new medical approach and new hope for patients. We hope that this recognition also serves others in this field in the Wallonia Region and enables us to consolidate our role as leader in our region in a very specialist area of regenerative medicine."